Sain Bel, France

Noëlle Mistretta

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2009-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Introduction

Noëlle Mistretta is a notable inventor based in Sain Bel, France, recognized for his contributions in the field of immunogenic compositions. With a total of four patents to his name, his work primarily focuses on advancements that aid in the treatment and prevention of infections.

Latest Patents

Mistretta's latest patents feature innovative constructs, including a conjugate of a saccharide covalently bound to a carrier protein. This conjugate is designed to comprise repetitive units of 1,5 ribitol phosphate, with all ribitol residues substituted by N-acetyl D-glucosaminyl residues at the 4-position. The specific configurations of the N-acetyl D-glucosaminyl residues bolster their functionality. Notably, Mistretta’s invention aims to develop multivalent vaccine compositions that are effective against infections, particularly those caused by serogroup B. One patent highlights a lipooligosaccharide (LOS) composed of lipid A and an inner core with strategic phosphoethanolamine (PEA) substitutions. These inventions position Mistretta on the cutting edge of vaccine development, paving the way for protective measures against significant strains of infection.

Career Highlights

Mistretta's professional journey includes significant tenures at major pharmaceutical companies, notably Sanofi Pasteur Inc. and Aventis Pasteur S.A. His experience in these esteemed organizations underscores his expertise in vaccine research and development, cementing his reputation as a leader in the innovation of immunogenic therapies.

Collaborations

Throughout his career, Noëlle Mistretta has worked closely with colleagues such as Monique Moreau and Bachra Rokbi. These collaborations have allowed him to enhance his research efforts and bring innovative solutions to the field of immunology.

Conclusion

Noëlle Mistretta stands out in the arena of medical innovation through his patents and collaborative endeavors. His work not only contributes significantly to the advancement of vaccine technology but also exemplifies the crucial role of inventors in shaping public health solutions. As he continues to innovate, Mistretta's contributions will likely have a lasting impact on the field of immunology and vaccine development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…